Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.28 +0.02 (+7.69%)
At close: Nov 6, 2026 · 4:00 PM EST

Anebulo Pharmaceuticals (ANEB) Receivables - Other (2020)

Updated

Anebulo Pharmaceuticals' Receivables - Other was $3,500 in fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Anebulo Pharmaceuticals (ANEB) Receivables - Other (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Anebulo Pharmaceuticals 11.50 Mn -32.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 3,500.00
API Access

Anebulo Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANEB&period=max&api_key=YOUR_API_KEY